Experts Question Link Between Tylenol and Autism
Numerous experts are challenging the Trump administration’s claims linking autism to Tylenol use. A new study indicates no definitive connection between using acetaminophen during pregnancy and an increased risk of autism or attention deficit/hyperactivity disorder (ADHD).
A team of researchers from the UK reviewed existing medical literature regarding acetaminophen and its possible association with autism and ADHD. They found mixed results in the studies analyzed; some suggested a potential link, while others did not. Overall, they concluded that the quality of the evidence is inadequate, making it difficult to attribute autism directly to the common medication.
“Our review shows the lack of robust evidence linking [acetaminophen] use in pregnancy and autism and ADHD in offspring,” the researchers stated in their paper published in The BMJ.
Responses to Recent Claims
In late September, President Trump and Health and Human Services Secretary Robert F. Kennedy Jr. held an event where they promoted their findings on autism, asserting that acetaminophen use during pregnancy could significantly increase the likelihood of autism in children. They indicated plans to warn pregnant women about potential risks, including adding warning labels to the medication.
However, many health experts and authorities criticized these declarations as lacking reliable support. Countries such as the UK, South Africa, and members of the European Union have rejected the report’s conclusions, choosing instead to affirm that acetaminophen remains a safe option for managing pain and fever during pregnancy.
Researchers from the University of Liverpool and other institutions conducted this recent study, which is essentially an umbrella review of previous systematic reviews on the topic. They analyzed information from nine reviews encompassing 40 studies focused on maternal acetaminophen use concerning autism and ADHD.
While some studies reported a connection between acetaminophen and these conditions, the researchers noted that these studies often had significant biases or other important limitations. Only one review included sibling comparisons, which is useful for mitigating shared genetic factors. Strikingly, these studies did not establish a causal relationship between acetaminophen and autism or ADHD.
The authors of the study argue that, despite the potential value of additional research, there is currently no strong evidence proving a causal link between acetaminophen and these developmental disorders. They suggested that apparent effects observed following in utero exposure could instead be influenced by genetic and environmental factors that have not been adequately measured.
Evidence and Acknowledgments
Interestingly, it seems that even the Trump administration recognizes the fragility of its claims. RFK Jr. has continued to support the administration’s viewpoint but has also admitted they lack definitive evidence establishing a direct connection. During a Cabinet meeting discussing the findings, he acknowledged, “It is not proof. We’re doing the studies to make the proof.” Later, he reiterated that they do not yet have “sufficient” evidence to conclude that Tylenol causes autism.
This cautious approach did not prevent Trump and RFK Jr. from asserting that they had discovered the cause of autism leading up to their September press conference. Throughout that announcement, Trump urged pregnant women to completely avoid the drug, while Kennedy has advocated for more measured use, which aligns with existing medical guidelines.
While these latest findings are unlikely to settle the debate definitively, it appears doubtful that the administration’s rationale for blaming Tylenol will hold up against scientific scrutiny in the long run.
